These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3300716)

  • 1. Vaccines, vaccination in brucellosis.
    Plommet M; Serre A; Fensterbank R
    Ann Inst Pasteur Microbiol; 1987; 138(1):117-21. PubMed ID: 3300716
    [No Abstract]   [Full Text] [Related]  

  • 2. Research progress in live attenuated Brucella vaccine development.
    Wang Z; Wu Q
    Curr Pharm Biotechnol; 2013; 14(10):887-96. PubMed ID: 24372253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermostable cross-protective subunit vaccine against Brucella species.
    Cherwonogrodzky JW; Barabé ND; Grigat ML; Lee WE; Poirier RT; Jager SJ; Berger BJ
    Clin Vaccine Immunol; 2014 Dec; 21(12):1681-8. PubMed ID: 25320267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Brucella melitensis M5-90ΔmanB live vaccine candidate is safer than M5-90 and confers protection against wild-type challenge in BALB/c mice.
    Zhang J; Yin S; Yi D; Zhang H; Li Z; Guo F; Chen C; Fang W; Wang J
    Microb Pathog; 2017 Nov; 112():148-155. PubMed ID: 28916316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of whole cell and subcellular vaccines against Brucella ovis in rams.
    Blasco JM; Gamazo C; Winter AJ; Jiménez de Bagüés MP; Marín C; Barberán M; Moriyón I; Alonso-Urmeneta B; Díaz R
    Vet Immunol Immunopathol; 1993 Aug; 37(3-4):257-70. PubMed ID: 8236802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipopolysaccharide as a target for brucellosis vaccine design.
    Conde-Álvarez R; Arce-Gorvel V; Gil-Ramírez Y; Iriarte M; Grilló MJ; Gorvel JP; Moriyón I
    Microb Pathog; 2013 May; 58():29-34. PubMed ID: 23219811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brucellosis: Improved Diagnostics and Vaccine Insights from Synthetic Glycans.
    Bundle DR; McGiven J
    Acc Chem Res; 2017 Dec; 50(12):2958-2967. PubMed ID: 29219305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy.
    Li ZQ; Shi JX; Fu WD; Zhang Y; Zhang J; Wang Z; Li TS; Chen CF; Guo F; Zhang H
    Mol Immunol; 2015 Aug; 66(2):276-83. PubMed ID: 25899866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of serological response of young and adult sheep to conjunctival vaccination with Rev-1 vaccine by fluorescence polarization assay (FPA) and other serological tests for B. melitensis.
    Stournara A; Minas A; Bourtzi-Chatzopoulou E; Stack J; Koptopoulos G; Petridou E; Sarris K
    Vet Microbiol; 2007 Jan; 119(1):53-64. PubMed ID: 16973307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards a Brucella vaccine for humans.
    Perkins SD; Smither SJ; Atkins HS
    FEMS Microbiol Rev; 2010 May; 34(3):379-94. PubMed ID: 20180858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the immune protection to murine experimental brucellosis conferred by Brucella fractions. I. Positive role of immune serum.
    Bascoul S; Cannat A; Huguet MF; Serre A
    Immunology; 1978 Aug; 35(2):213-21. PubMed ID: 750371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brucella abortus 2308ΔNodVΔNodW double-mutant is highly attenuated and confers protection against wild-type challenge in BALB/c mice.
    Li Z; Wang S; Zhang J; Yang G; Yuan B; Huang J; Han J; Xi L; Xiao Y; Chen C; Zhang H
    Microb Pathog; 2017 May; 106():30-39. PubMed ID: 28131952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization of BALB/c mice with Brucella abortus 2308ΔwbkA confers protection against wild-type infection.
    Li ZQ; Gui D; Sun ZH; Zhang JB; Zhang WZ; Zhang H; Guo F; Chen CF
    J Vet Sci; 2015; 16(4):467-73. PubMed ID: 26040616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 16MΔvjbR as an ideal live attenuated vaccine candidate for differentiation between Brucella vaccination and infection.
    Wang Y; Bai Y; Qu Q; Xu J; Chen Y; Zhong Z; Qiu Y; Wang T; Du X; Wang Z; Yu S; Fu S; Yuan J; Zhen Q; Yu Y; Chen Z; Huang L
    Vet Microbiol; 2011 Aug; 151(3-4):354-62. PubMed ID: 21530111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brucella melitensis 16MΔhfq attenuation confers protection against wild-type challenge in BALB/c mice.
    Zhang J; Guo F; Chen C; Li Z; Zhang H; Wang Y; Zhang K; Du G; Li Y; Wang J; Jian T; Wang Z
    Microbiol Immunol; 2013 Jul; 57(7):502-10. PubMed ID: 23647412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective antigens in brucellosis.
    Dubray G
    Ann Inst Pasteur Microbiol; 1987; 138(1):84-7. PubMed ID: 3300720
    [No Abstract]   [Full Text] [Related]  

  • 17. Meta-Analysis and Advancement of Brucellosis Vaccinology.
    Carvalho TF; Haddad JP; Paixão TA; Santos RL
    PLoS One; 2016; 11(11):e0166582. PubMed ID: 27846274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of in murine model, of an improved live-vaccine candidate against brucellosis from to Brucella melitensis vjbR deletion mutant.
    Li Z; Wang S; Zhang H; Xi L; Zhang J; Zhang X; Zhou Q; Yi J; Li M; Zhang W; Zhang J
    Microb Pathog; 2018 Nov; 124():250-257. PubMed ID: 30149131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge.
    Rajasekaran P; Surendran N; Seleem MN; Sriranganathan N; Schurig GG; Boyle SM
    Vaccine; 2011 Apr; 29(17):3106-10. PubMed ID: 21376799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Case for Live Attenuated Vaccines against the Neglected Zoonotic Diseases Brucellosis and Bovine Tuberculosis.
    Pandey A; Cabello A; Akoolo L; Rice-Ficht A; Arenas-Gamboa A; McMurray D; Ficht TA; de Figueiredo P
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004572. PubMed ID: 27537413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.